PATENT CLAIM ANALYSIS

Application Number: 16004744
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "569000"]

Abstract:
The present disclosure relates to a pharmaceutical composition for preventing or treating neurodegenerative diseases, the pharmaceutical composition including a graphene nanostructure as an active ingredient.

Claim (Index 3):
The method of  claim 1 , wherein the neurodegenerative diseases comprise a member selected from the group consisting of Alzheimer's disease, Parkinson's disease, Huntington's chorea, HIV dementia, stroke, senile systemic amyloidosis, primary systemic amyloidosis, secondary systemic amyloidosis, type II diabetes, amyotrophic amyloidosis, hemodialysis-related amyloidosis, transmissible spongiform encephalopathy, and multiple sclerosis.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 94.0
- Lexical Diversity: 1.125
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15827246', '15946087', '14747321', '14116102', '15644172']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7728014141217578
- 35 USC 102 Novelty (BERT): 0.5106736167296634
- Combined Prediction Score: 0.7465886343825484
- Mean Citation Score: 156.062498
- Max Citation Score: 187.87138
- Similarity Product: 100.7104617593455

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test